Chronix Blood Test Can Predict Cancer Patients’ Response to Immunotherapy, Study Shows – Immuno-Oncology News
Immuno-Oncology News |
Chronix Blood Test Can Predict Cancer Patients' Response to Immunotherapy, Study Shows
Immuno-Oncology News Chronix's test predicted treatment response and disease control or progression with 83 percent accuracy. It also predicted disease progression after one cycle of immunotherapy with 92 percent accuracy, and after two cycles with 100 percent accuracy. |
